ID   HAY
AC   CVCL_N813
DR   Cosmic; 1656049
DR   Wikidata; Q54881340
RX   PubMed=15274292;
RX   PubMed=22426987;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=22426987; DOI=10.3892/or.2012.1725; PMCID=PMC6310027;
RA   Kalra, Neetu
RA   Ashai, Ali
RA   Xi, Li-Qiang
RA   Zhang, Jing-Li
RA   Avital, Itzhak
RA   Raffeld, Mark
RA   Hassan, Raffit
RT   "Patients with peritoneal mesothelioma lack epidermal growth factor
RT   receptor tyrosine kinase mutations that would make them sensitive to
RT   tyrosine kinase inhibitors.";
RL   Oncol. Rep. 27:1794-1800(2012).
//
RX   PubMed=15274292;
RA   Li, Qian
RA   Verschraegen, Claire F.
RA   Mendoza, John T.
RA   Hassan, Raffit
RT   "Cytotoxic activity of the recombinant anti-mesothelin immunotoxin,
RT   SS1(dsFv)PE38, towards tumor cell lines established from ascites of
RT   patients with peritoneal mesotheliomas.";
RL   Anticancer Res. 24:1327-1335(2004).
//